The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
96400826 9640082 6 F 20150721 20160629 20131023 20160705 EXP PHHY2013CA093722 NOVARTIS 68.47 YR M Y 0.00000 20160705 MD CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
96400826 9640082 1 PS SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Intramuscular 30 MG, ONCE A MONTH (QMO) 21008 30 MG /month
96400826 9640082 2 SS SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Intramuscular 30 MG, EVERY FOUR WEEKS 21008 30 MG /month
96400826 9640082 3 SS SANDOSTATIN LAR DEPOT OCTREOTIDE ACETATE 1 Intramuscular 30 MG, Q2MO (30 MG EVERY 08 WEEKS) 21008 30 MG
96400826 9640082 4 SS SANDOSTATIN OCTREOTIDE ACETATE 1 Subcutaneous 50 UG, ONCE/SINGLE (TEST DOSE) 0 50 UG 1X

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
96400826 9640082 1 Neuroendocrine tumour
96400826 9640082 4 Neuroendocrine tumour

Outcome of event

Event ID CASEID OUTC COD
96400826 9640082 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
96400826 9640082 Blood pressure diastolic decreased
96400826 9640082 Diarrhoea
96400826 9640082 Dyspnoea
96400826 9640082 Hot flush
96400826 9640082 Inappropriate schedule of drug administration
96400826 9640082 Lung neoplasm
96400826 9640082 Pain
96400826 9640082 Peripheral swelling
96400826 9640082 Vital functions abnormal

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
96400826 9640082 1 20130529 20130826 0
96400826 9640082 4 20130503 20130503 0